Main content

    HealthWise KnowledgeBase

    Combination Antiviral Therapy for Hepatitis C

    Combination Antiviral Therapy for Hepatitis C



    References

    Citations

    1. McHutchison JG, et al. (2009). Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection. New England Journal of Medicine, 361(6): 580–593.

    2. Ward RP, et al. (2004). Management of hepatitis C: Evaluating suitability for drug therapy. American Family Physician, 69(6): 1429–1438.

    3. Chung RT, et al. (2004). Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. New England Journal of Medicine, 351(5): 451–459.

    4. Management of hepatitis C: 2002. Consensus Development Conference statement, National Institutes of Health Consensus Development Conference (2002 June 10–12). NIH Consensus Development Program. Available online: http://consensus.nih.gov/2002/2002HepatitisC2002116html.htm.

    5. Singal AK, et al. (2010). Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis, Clinical Gastroenterology and Hepatology, 8(2): 192–199.

    6. Dienstag JL (2010). Chronic viral hepatitis. In GL Mandell et al., eds., Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th ed., vol. 1, pp. 1593–1670. Philadelphia: Churchill Livingstone Elsevier.




    By: Reference Healthwise Staff Last Revised: May 14, 2012
    Medical Review: Reference E. Gregory Thompson, MD - Internal Medicine
    Reference W. Thomas London, MD - Hepatology


    This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Reference Terms of Use. Reference How this information was developed to help you make better health decisions.


    Topic Contents